# OnCo record nct06483555 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06483555/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06483555", "NCT06483555" ;
  schema:name "Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel"@en ;
  schema:alternateName "PANGEA"@en ;
  schema:description "A phase 1/2 trial of gemcitabine, nab-paclitaxel, erlotinib, nALIRIFOX (liposomal irinotecan + oxaliplatin + 5-FU/LV) and other drugs in pancreatic cancer, run by UNC Lineberger Comprehensive Cancer Center, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06483555/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06483555> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "pancreatic-deep-dive" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/borderline-resectable-pdac/>, <https://onco.cc/cancers/locally-advanced-pdac/>, <https://onco.cc/cancers/metastatic-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/nab-paclitaxel/>, <https://onco.cc/drugs/erlotinib/>, <https://onco.cc/drugs/nalirifox/>, <https://onco.cc/drugs/folfirinox/> .